13 research outputs found
The importance of preoperative elevated serum levels of CEA and CA15-3 in patients with breast cancer in predicting its histological type.
It is not known whether in patients with breast cancer the occurrence of elevated serum tumour markers depends on its histological type. The aim of the study was to assess relationship between breast cancer histological type and the presence of increased serum levels of CEA and CA 15-3. The study population was 428 patients (all women, mean age 52.5 years), treated at The Department of Surgery of Wroclaw Medical University from 2005 to 2008 due to breast cancer. All of them had their preoperative CA 15-3 and CEA serum concentrations measured. According to the TNM system, 21% of patients were in stage I, 32.5% in stage II, 46.5% in stage III of the disease. In patients with ductal type of the cancer the elevated serum levels of CEA and CA 15-3 were observed in 48.7% and 42.2%, in lobular type in 42.4% and 52.5%, and in non-ductal/tubular types in 48.1% and 40.4% (p=N/S). Stepwise logistic regression analyses showed that ductal breast cancer is related to elevated CEA and normal CA 15-3 serum levels. The histological types of breast cancer are not significantly related to elevated serum levels of CEA and/or CA 15-3
Prognostic value of CA 19-9 level in resectable pancreatic adenocarcinoma.
The prognosis in patients with pancreatic cancer is poor and some authors describe it as a lethal disease. At the time of diagnosis only 14% of patients could be surgically treated and up to 30% of them die within 12 months. Therefore, further clinical investigations on preoperative patient qualification are needed. A total of 81 patients were included into the study. The CA 19-9 concentration was measured before surgery by an automated, commercially available enzyme immunoassay in Axsym analyzer (Abott Diagnostics Laboratory). A value of 37 U/ml was used as the upper limit of normal levels. Tumors were staged according to the Union Against Cancer (UICC) of 2004 and graded during the histological evaluation according to the G0-G4 scale. All patients were monitored every three month via outpatient clinic visits. In the case of missing visit we contacted the families to establish the cause. We assessed perioperative, 12 month, 2 year and 5 year survival. Twelve moth, 2 year and 5 year survival were assessed in the whole studied population and in the group of patients with the exception of these who died during the perioperative period. The total five year survival was 6%. The median time of survival was 467 days (range: 163 - 586 days). The perioperative period was survived by 91.4% patients, 12 months were survived by 71.6% patients, 2 years were survived by 35.8% patients, 5 years were survived by 6.2% patients. The serum Ca 19-9 level was above the normal limit in 80.5% patients. ROC curve analysis revealed that CA 19-9 level of more than 106 U/ml was linked to 2 year survival with 79.3% sensitivity and 74.5% specificity. Preoperative level of CA 19-9 below 106U/ml represents a predictive factor of 2- and 5-year survival, independent of other factors, such as lower size of the tumor, absence of metastases to lymph nodes, female gender of patients. After exclusion of the patients who died in the perioperative period, no relationship could have been disclosed between preoperative CA 19-9 levels and one year survival. The observation points to the chance that patients with higher levels of CA 19-9 harbour micrometastases, the development of which is sufficiently slow to allow for a one-year survival of the patients but which increase the risk of death after two and five years
Analiza zale偶no艣ci pomi臋dzy obecno艣ci膮 receptor贸w androgenowych a innymi czynnikami prognostycznymi u kobiet chorych na raka gruczo艂u piersiowego
The importance of preoperative elevated serum levels of CEA and CA15-3 in patients with breast cancer in predicting its histological type.
Wyb贸r parametr贸w pracy wir贸wek paliwa do oceny ich zdatno艣ci
The various possible stages of the separator's work, including full and partial readiness to work and unserviceability have been considered. Oil separator transition through each of the working stages has been described. Typical oil separator damages have been specified. It has also been pointed out that there are possibilities to diagnose separators during their working time. The significance of separator starting time until the moment of achieving nominal working parameters has been emphasised. For the selected type of separator, nominal parameter values have been defined. The possibilities of measuring the oil separator working parameters and applying them to diagnose its ability to work have been described.Przedstawiono mo偶liwe stany pracy wir贸wek, uwzgl臋dniaj膮c stan pe艂nej zdatno艣ci, cz臋艣ciowej zdatno艣ci i niezdatno艣ci. Wskazano miejsca typowych uszkodze艅 wyst臋puj膮cych w wir贸wkach oleju. Wskazano na mo偶liwo艣膰 diagnozowania wir贸wek w czasie pracy i podkre艣lono znaczenie czasu rozruchu wir贸wki do momentu uzyskania parametr贸w nominalnych pracy. Dla wybranego typu wir贸wki przedstawiono nominalne warto艣ci parametr贸w pracy. Opisano mo偶liwo艣膰 pomiar贸w parametr贸w pracy wir贸wki i wykorzystanie ich do zdiagnozowania jej zdatno艣ci
Point Investigation Method for Cancer Changed Tissues
In this paper we describe the method of point investigation for cancer changed tissues with application of fluorescence phenomenon. The measurements have been made using a specially constructed scanning setup and fiber sensors. The experiment with investigation of endogenous fluorescence has been made on different types of slide tissues (e.g. breast and intestine tumor or precancerous and pathological skin tissues). The obtained spectral characteristics of fluorescence, with typical intensity peaks in 480-520 nm range, have explicitly outlined healthy and pathologically changed areas. The intensity of detected fluorescence determines the evaluation of disease advancement. Moreover, the ability to scan the surface of a tissue sample with constantly moving step of scanning setup in X-Y axis allows us to present the results in a spatial distribution of fluorescence intensity
Zarz膮dzanie reasekuracj膮 w zak艂adach ubezpiecze艅 w przypadku ubezpieczenia odpowiedzialno艣ci cywilnej og贸lnej
The importance of preoperative elevated serum levels of CEA and CA15-3 in patients with breast cancer in predicting its histological type.
It is not known whether in patients with breast cancer the occurrence of elevated serum tumour markers depends on its histological type. The aim of the study was to assess relationship between breast cancer histological type and the presence of increased serum levels of CEA and CA 15-3. The study population was 428 patients (all women, mean age 52.5 years), treated at The Department of Surgery of Wroclaw Medical University from 2005 to 2008 due to breast cancer. All of them had their preoperative CA 15-3 and CEA serum concentrations measured. According to the TNM system, 21% of patients were in stage I, 32.5% in stage II, 46.5% in stage III of the disease. In patients with ductal type of the cancer the elevated serum levels of CEA and CA 15-3 were observed in 48.7% and 42.2%, in lobular type in 42.4% and 52.5%, and in non-ductal/tubular types in 48.1% and 40.4% (p=N/S). Stepwise logistic regression analyses showed that ductal breast cancer is related to elevated CEA and normal CA 15-3 serum levels. The histological types of breast cancer are not significantly related to elevated serum levels of CEA and/or CA 15-3
The pharmacokinetics and safety of porfimer after repeated administration 30-45 days apart to patients undergoing photodynamic therapy
The pharmacokinetics and safety of porfimer after repeated administration 30-45 days apart to patients undergoing photodynamic therapy
Porfimer is an intravenous (i.v.) injectable photosensitizing agent used in the photodynamic treatment of tumours and of high-grade dysplasia in Barrett's oesophagus